000			01835 a2200481 4500
005			20250517010359.0
264		0	_c20150813
008			201508s 0 0 eng d
022			_a2476-762X
024	7		_a10.7314/apjcp.2014.15.22.9909 _2doi
040			_aNLM _beng _cNLM
100	1		_aSrinarong, Chanagune
245	0	0	_aImproved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. _h[electronic resource]
260			_bAsian Pacific journal of cancer prevention : APJCP _c2014
300			_a9909-13 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAmoxicillin _xtherapeutic use
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aBismuth _xtherapeutic use
650	0	4	_aClarithromycin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGastritis _xdrug therapy
650	0	4	_aHelicobacter Infections _xdrug therapy
650	0	4	_aHelicobacter pylori _xdrug effects
650	0	4	_aHumans
650	0	4	_aLansoprazole _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganometallic Compounds _xtherapeutic use
650	0	4	_aProbiotics _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aSalicylates _xtherapeutic use
650	0	4	_aThailand
700	1		_aSiramolpiwat, Sith
700	1		_aWongcha-um, Arti
700	1		_aMahachai, Varocha
700	1		_aVilaichone, Ratha-korn
773	0		_tAsian Pacific journal of cancer prevention : APJCP _gvol. 15 _gno. 22 _gp. 9909-13
856	4	0	_uhttps://doi.org/10.7314/apjcp.2014.15.22.9909 _zAvailable from publisher's website
999			_c24468902 _d24468902